FMR CORP 13D and 13G filings for CYTEIR THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-10 10:20 am Sale |
2023-07-07 | 13G | CYTEIR THERAPEUTICS INC CYTT |
FMR CORP | 827,867 2.331% |
-2,080,509 (-71.54%) |
Filing |
| 2023-02-09 09:59 am Sale |
2023-02-09 | 13G | CYTEIR THERAPEUTICS INC CYTT |
FMR CORP | 2,908,376 8.206% |
-1,140,617 (-28.17%) |
Filing |
| 2022-02-09 09:11 am Sale |
2022-02-08 | 13G | CYTEIR THERAPEUTICS INC CYTT |
FMR CORP | 4,048,993 11.447% |
-236,666 (-5.52%) |
Filing |
| 2021-10-12 09:25 am Purchase |
2021-10-08 | 13G | CYTEIR THERAPEUTICS INC CYTT |
FMR CORP | 4,285,659 12.116% |
4,285,659 (New Position) |
Filing |